Sands Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-1,479,909
| Closed | -$480M | – | 79 |
|
2020
Q4 | $480M | Sell |
1,479,909
-15,056
| -1% | -$4.88M | 0.91% | 37 |
|
2020
Q3 | $414M | Buy |
1,494,965
+30,501
| +2% | +$8.45M | 0.9% | 38 |
|
2020
Q2 | $354M | Buy |
1,464,464
+3,610
| +0.2% | +$872K | 0.86% | 39 |
|
2020
Q1 | $212M | Sell |
1,460,854
-980,222
| -40% | -$142M | 0.71% | 38 |
|
2019
Q4 | $416M | Buy |
2,441,076
+500,246
| +26% | +$85.3M | 1.21% | 29 |
|
2019
Q3 | $345M | Sell |
1,940,830
-195,596
| -9% | -$34.8M | 1.11% | 30 |
|
2019
Q2 | $557M | Buy |
2,136,426
+835,078
| +64% | +$218M | 1.66% | 21 |
|
2019
Q1 | $372M | Buy |
1,301,348
+448,988
| +53% | +$128M | 1.15% | 27 |
|
2018
Q4 | $277M | Buy |
852,360
+408,753
| +92% | +$133M | 0.99% | 32 |
|
2018
Q3 | $200M | Buy |
+443,607
| New | +$200M | 0.56% | 37 |
|